Eris Lifesciences' Q1 profit jumps 21%, but margins come under pressure

Eris Lifesciences’ Q1 profit jumps 21%, but margins come under pressure

Gujarat-headquartered Eris Lifesciences reported a 20.7% year-on-year increase in consolidated profit after tax (PAT) attributable to owners at ₹142.39 crore for the quarter ended June 30, 2026, compared with ₹117.99 crore a year earlier. Revenue from operations rose 13% to ₹873.25 crore from ₹773 crore, while earnings before interest, taxes, depreciation and amortisation (EBITDA) increased…

Read More
Dabur Q1 Results: Profit beats estimates, but volume growth misses Street view

Dabur Q1 Results: Profit beats estimates, but volume growth misses Street view

Dabur India delivered another quarter of broad-based growth despite navigating a difficult operating environment marked by persistent inflation, volatile commodity prices and geopolitical uncertainty in the Middle East. While the FMCG major reported a better-than-expected profit and its third consecutive quarter of double-digit earnings growth, domestic volume growth of 5% fell short of CNBC-TV18’s expectation…

Read More
TeamLease Q1 profit jumps 31% despite softer hiring demand; revenue tops ₹3,000 crore

TeamLease Q1 profit jumps 31% despite softer hiring demand; revenue tops ₹3,000 crore

People supply chain company TeamLease Services Ltd reported a 31.4% year-on-year rise in consolidated net profit for the June quarter at ₹34.9 crore, compared with ₹26.5 crore in the corresponding period last year. Revenue from operations increased 5.8% to ₹3,034.7 crore from ₹2,869.4 crore a year earlier. EBITDA rose 2.7% to ₹31.5 crore during the…

Read More
Record MTF exposure worries Zerodha's Nithin Kamath as leverage builds in markets

Record MTF exposure worries Zerodha’s Nithin Kamath as leverage builds in markets

Zerodha founder and CEO Nithin Kamath has flagged the rapid growth in margin trading as the biggest risk facing the brokerage, warning that a sharp correction in Indian equities could trigger forced selling, particularly in small- and mid-cap stocks. Drawing parallels with the recent turmoil in South Korea’s stock market, Kamath said his “biggest nightmare…

Read More